1Connor EM,Sperling RS,Gelber R,et al.Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment.Pediatric AIDS clinical trials group protocol 076 study group[J].N Engl J Med,1994,331:1173-1180.
3Connor E,Wang Z,Stephens R,et al.Enzyme immunoassay for detection of human immunodeficiency virus-specific immunoglobulin A antibodies[J].Clin Microbiol,1993,31(3):681-684.
4Beck IA,Drennan KD,Melvin AJ,et al.Simple,Sensitive,and Specific Detection of Human Immunodeficiency Virus Type 1 Subtype B DNA in Dried Blood Samples for Diagnosis in Infants in the field[J].J Clin Microbiol,2001,39(1):29-33.
5Fischer A,Lejczak C,Lambert C,et al.Simple DNA Extraction Method for Dried Blood Spots and Comparison of Two PCR Assays for Diagnosis of Vertical Human Immunodeficiency Virus Type 1 Transmission in Rwanda[J].J Clin Microbiol,2004,42(1):16-20.
3Mclntyre J A. Controversies in the use of nevirapine for prevention of mother-to-child transmission of HIV[J]. Expert Opin pharmacother, 2006,7 (6) : 677-685.
4Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. Pediatric AIDS clinical trials group protocol 076 study group[J]. NEngl J Med,1994,331:1173-1180.
5Jasseron C, Mandelbrot L, Tubiana R, et al. Prevention of motherto - child HIV transmission:Similar access for subSahara African immigrants and for French women [J]. AIDS,2008,22(12) :1503-1511.
8Newell ML. Mechanisms and timing of mother-to-child transmis sion of HIV-1 [J]. AIDS, 1998, 12(8):831-837.
9Mandelbrot L, Mayaux MJ, Bongain A, et al. Obstetric factors and mother-to-child transmission of human immunodeficiency vi- rus type 1 : The French perinatal cohorts [J]. Am J Obstet Gyne- col, 1996, 175(3, Part 1).. 661-667.
10Magoni M, Bassani L, Okong P, et al. Mode of infant feeding and HIV infection in children in a program for prevention of mother-to-child transmission in Uganda [J]. AIDS, 2005,19 (4) : 433-437.
